Article
Machine Learning for Predicting and Maximizing the Response of Breast Cancer Patients to Neoadjuvant Therapy
2025-10-14
Abstract excerpt
<h4>Purpose</h4> Neoadjuvant therapy (NAT) is an established treatment for certain high-risk, locally advanced, or unresectable breast cancers, often facilitating breast-conserving surgery. Recent studies show that achieving pathologic complete response (pCR) after NAT correlates with higher event-free survival rates. Thus, accurate prediction of pCR is essential for personalizing breast cancer (BC) treatment to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ff62066d-9690-5963-8926-397128c071fa
- DOI
- 10.1101/2025.10.11.25337587
